Stockscreener 앱 받기
2.40
3.23%
-0.08
시간 외 거래:
2.43
0.03
+1.25%
전일 마감가:
$2.48
열려 있는:
$2.44
하루 거래량:
215.35K
Relative Volume:
0.09
시가총액:
$3.20M
수익:
$9.81M
순이익/손실:
$-26.16M
주가수익비율:
-0.0619
EPS:
-38.77
순현금흐름:
$-17.45M
1주 성능:
-17.53%
1개월 성능:
-1.64%
6개월 성능:
-97.37%
1년 성능:
-99.18%
1일 변동 폭
$2.40
$2.48
1주일 범위
$2.40
$3.49
52주 변동 폭
$2.23
$311.46
Reshape Lifesciences Inc Stock (RSLS) Company Profile
명칭
Reshape Lifesciences Inc
전화
949-429-6680
주소
1001 CALLE AMANECER, SAN CLEMENTE
RSLS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
2.40 | 5.92M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
126.35 | 220.16B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.84 | 157.03B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
400.69 | 154.21B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.97 | 119.08B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.49 | 46.93B | 5.69B | 4.15B | 623.10M | 6.95 |
Reshape Lifesciences Inc 주식(RSLS)의 최신 뉴스
What are analysts’ price targets for ReShape Lifesciences Inc. in the next 12 monthsTrack high-yield stocks before they peak - jammulinksnews.com
How strong is ReShape Lifesciences Inc. company’s balance sheetUnprecedented profits - jammulinksnews.com
How does ReShape Lifesciences Inc. generate profit in a changing economyAchieve impressive returns with smart timing - jammulinksnews.com
What are the latest earnings results for ReShape Lifesciences Inc.Capitalize on trading strategies that deliver - jammulinksnews.com
What are the technical indicators suggesting about ReShape Lifesciences Inc.Gain insights from top financial experts - jammulinksnews.com
Is it the right time to buy ReShape Lifesciences Inc. stockMaximize returns with disciplined trading approaches - jammulinksnews.com
Why ReShape Lifesciences Inc. stock attracts strong analyst attentionDouble Your Capital Alerts - metal.it
ReShape Lifesciences Holds Special Stockholder Meeting - TipRanks
ReShape Lifesciences Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - Autocar Professional
What drives ReShape Lifesciences Inc. stock priceTremendous growth potential - PrintWeekIndia
What analysts say about ReShape Lifesciences Inc. stockPhenomenal capital appreciation - Autocar Professional
Will ReShape Lifesciences Inc. stock split in the near futureOverwhelming profit margins - jammulinksnews.com
ReShape Lifesciences Announces Partial Adjournment of Stockholder Meeting for Asset Sale and Charter Amendment Proposals - Nasdaq
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders - GlobeNewswire
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Is ReShape Lifesciences Inc. a good long term investmentHigh-profit stock alerts - jammulinksnews.com
ReShape's New Lap-Band 2.0 FLEX Targets GLP-1 Era: Top Surgeons Gather for Groundbreaking Summit - Stock Titan
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit - GlobeNewswire
ReShape Lifesciences Hosts Special Meeting of Stockholders on July 24, 2025 - AInvest
ReShape Lifesciences Board Unanimously Recommends Merger with Vyome Therapeutics and Sale of Assets to Biorad Medisys - Nasdaq
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System - Yahoo.co
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewswire
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - Benzinga
How high can ReShape Lifesciences Inc. stock price go in 2025Free Access to Community - Newser
ReShape Lifesciences Announces Merger with Vyome Therapeutics - The Globe and Mail
What makes ReShape Lifesciences Inc. stock price move sharplyFree Join Group - Newser
Reshape Lifesciences Inc (RSLS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.71%
1.71%
자본화:
|
볼륨(24시간):